France approved the use of the Nuvaxovid coronavirus vaccine – Teller Report Teller Report

The French Higher Committee of Health (HAS) recommended Nuvaxovid, manufactured by the American company Novavax, for use. This was reported in the press service of the regulator.

France approves Nuvaxovid coronavirus vaccine

“Two recent findings from the European Medicines Agency (EMA) now allow HAS to expand its COVID-19 vaccination strategy and, as a result, expand the number of drugs due to the appearance of a fifth vaccine, Nuvaxovid,” TASS reports.

As specified, this drug can also be used as a second dose for those who have received the first shot with one of the other four approved drugs.

In addition, the regulator does not recommend the use of Nuvaxovid for revaccination, as there is still little data on the use of this drug.

Formerly European Medicines Agency recommended to issue a temporary registration certificate for the Nuvaxovid vaccine.

Error in the text? Select it and press “Ctrl + Enter”
Add RT to your sources list

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button